-
Patient-Reported Outcomes of CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients and Their Impact on Survival
Spanjaart, A. M., Coz, E., Rioufol, C., Maucort-Boulch, D., Roche, S., Beijamini, V., Vledder, A., Ghesquieres, H., Kersten, M. J. & da Silva, M. G., 2025, (E-pub ahead of print) In: Transplantation and Cellular Therapy.Research output: Contribution to journal › Article › Academic › peer-review
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Spanjaart, A. M., Ljungman, P., Tridello, G., Schwartz, J., Martinez-Cibrián, N., Barba, P., Kwon, M., Lopez-Corral, L., Martinez-Lopez, J., Ferra, C., di Blasi, R., Ghesquieres, H., Mutsaers, P., Calkoen, F., Jak, M., van Doesum, J., Vermaat, J. S. P., van der Poel, M., Maertens, J. & Gambella, M. & 22 others, , Sept 2024, In: Leukemia. 38, 9, p. 1985-1991 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
Kuipers, M. T., Spanjaart, A. M., Bonifazi, F., diBlasi, R., Zinzani, P. L., Thieblemont, C., Baudet, M., Biemond, B. J., Kok, W. E. M. & Kersten, M. J., 2024, In: Leukemia & lymphoma. 65, 3, p. 399-402 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications
